156 related articles for article (PubMed ID: 6146342)
1. Enzyme induction and beta-adrenergic receptor blocking drugs.
Branch RA; Herman RJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
[TBL] [Abstract][Full Text] [Related]
2. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
3. Induction of propranolol metabolism by rifampicin.
Herman RJ; Nakamura K; Wilkinson GR; Wood AJ
Br J Clin Pharmacol; 1983 Nov; 16(5):565-9. PubMed ID: 6639842
[TBL] [Abstract][Full Text] [Related]
4. A re-evaluation of intersubject variation in enzyme induction in man.
Branch RA; Shand DG
Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
[TBL] [Abstract][Full Text] [Related]
5. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
6. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park BK
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):3S-10S. PubMed ID: 6146338
[TBL] [Abstract][Full Text] [Related]
7. Influence of age and smoking on drug kinetics in man: studies using model compounds.
Vestal RE; Wood AJ
Clin Pharmacokinet; 1980; 5(4):309-19. PubMed ID: 6994978
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug interactions with propranolol.
Wood AJ; Feely J
Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
[TBL] [Abstract][Full Text] [Related]
9. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
10. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
11. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.
Bax ND; Lennard MS; Tucker GT
Br J Clin Pharmacol; 1981 Dec; 12(6):779-84. PubMed ID: 6122461
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine drug-drug interactions commonly occurring in clinical practice.
Abernethy DR; Greenblatt DJ; Ochs HR; Shader RI
Curr Med Res Opin; 1984; 8 Suppl 4():80-93. PubMed ID: 6144465
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Shand DG
Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
[No Abstract] [Full Text] [Related]
15. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
17. Effect of rifampicin treatment on the kinetics of mexiletine.
Pentikäinen PJ; Koivula IH; Hiltunen HA
Eur J Clin Pharmacol; 1982; 23(3):261-6. PubMed ID: 6129140
[TBL] [Abstract][Full Text] [Related]
18. The effect of rifampicin on norethisterone pharmacokinetics.
Back DJ; Breckenridge AM; Crawford F; MacIver M; Orme ML; Park BK; Rowe PH; Smith E
Eur J Clin Pharmacol; 1979 Apr; 15(3):193-7. PubMed ID: 37091
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of antipyrine metabolism by rifampicin.
Toverud EL; Boobis AR; Brodie MJ; Murray S; Bennett PN; Whitmarsh V; Davies DS
Eur J Clin Pharmacol; 1981; 21(2):155-60. PubMed ID: 7341283
[TBL] [Abstract][Full Text] [Related]
20. The influence of enzyme induction on polymorphic sparteine oxidation.
Eichelbaum M; Mineshita S; Ohnhaus EE; Zekorn C
Br J Clin Pharmacol; 1986 Jul; 22(1):49-53. PubMed ID: 3741726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
